Abstract
In a search of new compounds active against cancer, synthesis of a series of C-5 curcumin analogues was carried out. The new compounds demonstrated good cytotoxicity against chronic myeloid leukemia (KBM5) and colon cancer (HCT116) cell lines. Further, these compounds were found to have better potential to inhibit TNF-α-induced NF-κB activation in comparison to curcumin, which show their potential to act as anti-inflammatory agents. Some compounds were found to show higher cytotoxicity against cancer cell lines in comparison to curcumin used as standard.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Inflammatory Agents / pharmacology
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Cell Death / drug effects
-
Cell Line, Tumor
-
Curcumin / analogs & derivatives*
-
Curcumin / chemical synthesis*
-
Curcumin / chemistry
-
Curcumin / pharmacology
-
Down-Regulation / drug effects
-
Electrophoretic Mobility Shift Assay
-
Humans
-
NF-kappa B / metabolism*
-
Tumor Necrosis Factor-alpha / pharmacology*
Substances
-
Anti-Inflammatory Agents
-
Antineoplastic Agents
-
NF-kappa B
-
Tumor Necrosis Factor-alpha
-
Curcumin